1. I. Drugs in Preclinical and Early Clinical Development. EpilepsiaProgress Report on New Antiepileptic Drugs: A Summary of the Fourteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIV).59October 102018;Bialer;Progress Report on New Antiepileptic Drugs: A Summary of the Fourteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIV).,2018
2. II. Drugs in More Advanced Clinical Development.t. Epilepsia. 2018Progress Report on New Antiepileptic Drugs: A Summary of the Fourteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIV).59Oct ober102018;Bialer;Progress Report on New Antiepileptic Drugs: A Summary of the Fourteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIV).,2018
3. Prediction of seizure likelihood with a long-term, implanted seizure advisory system in patients with drug-resistant epilepsy: a first-in-man study;Cook;Lancet Neurol.,2013
4. 30 years of neuromodulation trials in epilepsy: do we need neuromodulation-specific trial designs?;Dibué-Adjei;Epilepsy Res.,2019
5. Lessons learned from transcutaneous vagus nerve stimulation (tVNS);Hamer;Epilepsy Res.,2019